Anteris Technologies Global Corp.

AVR ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024
Revenue $1.9M $2.7M
Cost of Revenue $569.0K $1.4M
Gross Profit $1.3M $1.3M
Gross Margin 70.3% 46.8%
Operating Expenses
Research & Development $69.1M $51.5M
SG&A Expense $26.1M $28.2M
Operating Income $-93.9M $-78.4M
Operating Margin -4,908.2% -2,899.4%
Interest Expense $73.0K $47.0K
Pretax Income $-94.2M $-76.0M
Income Tax Expense $0 $0
Net Income $-94.1M $-76.3M
Net Margin -4,921.3% -2,822.5%
EPS (Basic) $-2.55 $-3.68
EPS (Diluted) $-2.55 $-3.68
Shares Outstanding (Basic) 36.9M 20.3M
Shares Outstanding (Diluted) 36.9M 20.3M
Dividends Per Share